日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmaceutical governance system for costly drugs through human rights due diligence

通过人权尽职调查对高价药物进行药品治理

Lemmens, Trudo; Ghimire, Kanksha Mahadevia; Perehudoff, Katrina; Kohler, Jillian Clare; Low, Eric; Persaud, Navindra

Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors

循环肿瘤DNA和组织检测在胰胆肿瘤诊断中的应用

Mahadevia, Himil; Majeed, Umair; Patel, Jaydeepbhai; Ahmed, Ahmed K; Elhariri, Ahmed; Albelal, Douaa; Rao, Nakka Naga Malleswara; Rachamala, Hari Krishnareddy; Mosalem, Osama; Mukhopadhyay, Debabrata; Jones, Jeremy; Mahadevan, Daruka; Borad, Mitesh J; Ahn, Daniel; Sonbol, Mohamad Bassam; Tran, Nguyen; Mahipal, Amit; Wee Ma, Wen; McWilliams, Robert R; Halfdanarson, Thor R; Kankeu Fonkoua, Lionel A; Bekaii-Saab, Tanios; Mody, Kabir; Babiker, Hani

Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study

阿米万单抗联合化疗治疗EGFR 20号外显子插入突变的非小细胞肺癌:PAPILLON III期研究中治疗交叉及其他终点的影响

Sanborn, Rachel E; Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Cheng, Susanna; Popat, Sanjay; Ono, Akira; Lu, Shun; Majem, Margarita; Aguilar, Andres; Del Rosario Garcia Campelo, Maria; Hayashi, Hidetoshi; Lee, Kang-Yun; Lee, Se-Hoon; Delmonte, Angelo; Alatorre-Alexander, Jorge; Richardson, Gary; Santos, Victor; Dooms, Christophe; Sabari, Joshua K; Shu, Catherine A; Girard, Nicolas; Mansfield, Aaron S; Park, Keunchil; Xia, Yichuan; Bhattacharya, Archan; Buyukkaramikli, Nasuh; Perualila, Nolen; Diels, Joris; Acharya, Sandip; Chandler, Conor; Proskorovsky, Irina; Dearden, Lindsay; Wortman-Vayn, Honeylet; Mahadevia, Parthiv J; Knoblauch, Roland E; Agrawal, Trishala; Baig, Mahadi; Felip, Enriqueta

Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials

慢性淋巴细胞白血病患者使用布鲁顿酪氨酸激酶抑制剂治疗时肺炎的发生率:临床试验的系统评价和荟萃分析

Mahadevia, Himil; Ponvilawan, Ben; Shrestha, Anuj

A review on disease modifying pharmacologic therapies for sickle cell disease

镰状细胞病疾病修饰药物疗法综述

Mahadevia, Himil; Ponvilawan, Ben; Madan, Ujjwal; Sharma, Parth; Qasim, Hana; Shrestha, Anuj

Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and SMAD4 as a predictor of progression-free survival

立体定向放射治疗在寡转移性胰腺癌中的应用:总生存期改善及SMAD4作为无进展生存期预测因子

Elhariri, Ahmed; Patel, Jaydeepbhai; Mahadevia, Himil; Modi, Karnav; Albelal, Douaa; Majeed, Umair; Jones, Jeremy C; Borad, Mitesh J; Tran, Nguyen H; Rutenberg, Michael S; Babiker, Hani

Double Whammy: A Case Report of Immune Checkpoint Inhibitor Colitis and Concomitant Cytomegalovirus Colitis in a Patient on Nivolumab

双重打击:一例接受纳武利尤单抗治疗的患者发生免疫检查点抑制剂结肠炎和巨细胞病毒性结肠炎的病例报告

Gautam, Misha; Jahagirdar, Vinay; Mahadevia, Himil; Sanders, Kimberly; Campbell, John P; Sylvestre, Pamela B; Chhabra, Rajiv; Clarkston, Wendell; Jonnalagadda, Sreenivasa S

Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series

免疫检查点抑制剂诱发肺癌噬血细胞性淋巴组织细胞增生症:病例系列研究

Khan, Abdul Wali; Chandra, Simran; Mahadevia, Himil; Subramanian, Janakiraman; Ponvilawan, Ben; Bansal, Dhruv

The aggravating fury rituximab obliterated

利妥昔单抗消除了加剧愤怒的症状

Mahadevia, Himil; Al-Obaidi, Ammar; Cossor, Furha

Exceptional synergistic response of PARP inhibitor and immune checkpoint inhibitor in esophageal adenocarcinoma with a germline BRCA2 mutation: a case report

PARP抑制剂和免疫检查点抑制剂在携带BRCA2种系突变的食管腺癌中表现出卓越的协同作用:病例报告

Mahadevia, Himil; Ponvilawan, Ben; Al-Obaidi, Ammar; Buckley, Jennifer; Subramanian, Janakiraman; Bansal, Dhruv